Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
ABBV Stock vs. Eli Lilly & Merck
08:20am, Thursday, 02'nd Oct 2025
AbbVie stock (NYSE: ABBV) rallied 11% in a week, largely driven by a key development that boosted the entire sector: Pfizer's agreement to lower its drug prices for Medicaid and a White House decision
3 Blue Chip Stocks That Have Soared 380% (and Higher) Over the Past 5 Years
05:27am, Thursday, 02'nd Oct 2025
Normally when you think about earning big returns from the stock market, you're likely to remember risky investments that ended up paying off. But by no means is that the only case.
Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say
05:05am, Thursday, 02'nd Oct 2025
Novo Nordisk's and Eli Lilly's blockbuster weight-loss drugs should be the first medicines doctors reach for to treat obesity and its complications, a major European medical association advised on Thu
Another Surging Pharma Stock to Watch Right Now
01:53pm, Wednesday, 01'st Oct 2025
Pharmaceutical concern Eli Lilly And Co (NYSE:LLY ) is charging 7.2% higher to trade at $821.20 this afternoon.
Top Stock Movers Now: Nike, Eli Lilly, Corteva, AES, and More
01:30pm, Wednesday, 01'st Oct 2025
The S&P 500, Dow, and Nasdaq were little changed Wednesday afternoon, as a federal government shutdown took effect.
Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look Away
10:49am, Wednesday, 01'st Oct 2025
Pfizer Inc's (NYSE:PFE) deal with Washington isn't just a handshake in the Oval Office — it's a seismic jolt to America's drug-pricing game. By agreeing to sell medicines on the government's new Tru
Drug-Pricing Deals And Discounted Bets: Why LLY Stock Is A Core Pick In Our Top 10
08:25am, Wednesday, 01'st Oct 2025
Eli Lilly stock (NYSE: LLY) surged 5% yesterday, initially driven by news of a Pfizer deal with the White House to lower drug prices in exchange for tariff immunity. Following this, reports surfaced t
Eli Lilly in negotiations with Trump administration for the next pharma deal
03:12pm, Tuesday, 30'th Sep 2025
CNBC's Eamon Javers reports on news regarding the White House.
Is Lilly (LLY) a Buy as Wall Street Analysts Look Optimistic?
10:31am, Tuesday, 30'th Sep 2025
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
These 2 Top Dividend Stocks Are Finally Rebounding, and There Might Be More Upside Ahead
04:15am, Tuesday, 30'th Sep 2025
Apple (AAPL -0.43%) and Eli Lilly (LLY 0.12%) have faced significant volatility this year. However, both companies have benefited from recent positive developments, and their shares surged over the pa
3 Growth Stocks to Invest $1,000 Right Now
09:06pm, Monday, 29'th Sep 2025
Those who succeed at building wealth in the stock market often do so by buying and holding stakes in companies that have the ability to expand steadily over time. Such companies can frequently be foun
Eli Lilly: Strong Buy On Sustained Growth, Expanding Moat, And Pipeline Depth
10:26am, Monday, 29'th Sep 2025
Eli Lilly's valuation has compressed significantly from last year's highs, despite fundamentals improving faster than its share price. Industry-leading incretin treatments (Mounjaro, Zepbound) are dri
LLY Stock Set For A 20% Breakout?
09:35am, Monday, 29'th Sep 2025
Eli Lilly stock (NYSE: LLY) should be on your radar. Here's why – it is presently trading within the support range ($688 – $761), price points from which it has previously bounced significantly.
Novo, Lilly Weight-Loss Drugs May Help Alzheimer's Patients. What It Means for the Stocks.
02:00am, Monday, 29'th Sep 2025
The blockbuster medications could open a new frontier for the pharma giants.
Many pharma companies already made U.S. investment promises, says Citi's Geoff Meacham
04:50pm, Friday, 26'th Sep 2025
CNBC's “Closing Bell Overtime” team discusses President Trump's plan to impose a 100% tariff on “all any branded or patented Pharmaceutical Product” entering the U.S. with Geoff Meacham of Cit
